![Robert Dolski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Dolski
Financieel Directeur/CFO bij
AUTOLUS THERAPEUTICS PLC
Vermogen: - $ op 31-05-2026
Profiel
Robert Dolski is Chief Financial Officer at Autolus Therapeutics Plc starting in 2025.
Former roles include Chief Financial & Accounting Officer at Akcea Therapeutics, Inc. in 2020, Vice President, Head-Financial Planning & Analysis at Moderna, Inc. from 2016 to 2019, Senior Director-Finance at FORUM Pharmaceuticals, Inc. from 2013 to 2016, Vice President-Finance & Treasury at Human Genome Sciences, Inc. from 2007 to 2012, and Chief Financial Officer at Checkmate Pharmaceuticals, Inc. Education includes undergraduate studies at the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Robert Dolski
| Bedrijven | Functie | Begin |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Financieel Directeur/CFO | 07-08-2023 |
Eerdere bekende functies van Robert Dolski
| Bedrijven | Functie | Einde |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Financieel Directeur/CFO | 18-05-2020 |
| MODERNA, INC. | Corporate Officer/Principal | 01-05-2019 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Corporate Officer/Principal | 01-06-2016 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 01-12-2012 |
| CHECKMATE PHARMACEUTICALS, INC. | Financieel Directeur/CFO | - |
Opleiding van Robert Dolski
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
50
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Kies MarketScreener 
